| Title: | Constitutive CD40 Signaling in B Cells Selectively Activates the Noncanonical NF-κB Pathway and Promotes Lymphomagenesis |
| Author: |
Hömig-Hölzel, Cornelia; Hojer, Caroline; Rastelli, Julia; Casola, Stefano; Strobl, Lothar J.; Müller, Werner; Quintanilla-Martinez, Leticia; Gewies, Andreas; Ruland, Jürgen; Zimber-Strobl, Ursula; Rajewsky, Klaus
Note: Order does not necessarily reflect citation order of authors. |
| Citation: | Hömig-Hölzel, Cornelia, Caroline Hojer, Julia Rastelli, Stefano Casola, Lothar J. Strobl, Werner Müller, Leticia Quintanilla-Martinez, et al. 2008. Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis. The Journal of Experimental Medicine 205(6): 1317-1329. |
| Full Text & Related Files: |
2413030.pdf (4.684Mb; PDF)
|
| Abstract: | CD40, a member of the tumor necrosis factor (TNF) receptor family, plays an essential role in T cell–dependent immune responses. Because CD40 is widely expressed on the surface of tumor cells in various B cell malignancies, deregulated CD40 signaling has been suggested to contribute to lymphomagenesis. In this study, we show that B cell-specific expression of a constitutively active CD40 receptor, in the form of a latent membrane protein 1 (LMP1)/CD40 chimeric protein, promoted an increase in the number of follicular and marginal zone B cells in secondary lymphoid organs in transgenic mice. The B cells displayed an activated phenotype, prolonged survival and increased proliferation, but were significantly impaired in T cell-dependent immune responses. Constitutive CD40 signaling in B cells induced selective and constitutive activation of the noncanonical NF-κB pathway and the mitogen-activated protein kinases Jnk and extracellular signal–regulated kinase. LMP1/CD40-expressing mice older than 12 mo developed B cell lymphomas of mono- or oligoclonal origin at high incidence, thus showing that the interplay of the signaling pathways induced by constitutive CD40 signaling is sufficient to initiate a tumorigenic process, ultimately leading to the development of B cell lymphomas. |
| Published Version: | doi:10.1084/jem.20080238 |
| Other Sources: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413030/pdf/ |
| Terms of Use: | This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA |
| Citable link to this page: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:4874777 |
Contact administrator regarding this item (to report mistakes or request changes)